Improving postoperative MR imaging of pituitary macroadenomas: Comparison of full and reduced dose of gadopentetate dimeglumine

European Radiology

Volumn 10, Issue 7, 2000, Pages 1068-1072

  Hald, J K ^a   Eldevik, O P ^b   Dunn, R L ^c   Bakke, S J ^a   Pedersen, H K ^a   Nakstad, P H ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Contrast medium; Cost benefit; Magnetic resonance imaging; Surgically treated macroadenomas

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; POSTOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 0033938188     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300000455     Document Type: Article

References (18)

1. Hasso AN (1993) Current status of enhanced magnetic resonance imaging in neuroradiology. Invest Radiol 28 (Suppl 1):S3-S20
2. Giacometti AR, Joseph GJ, Peterson JE, Davis PC (1993) Comparison between full- and half-dose gadolinium-DTPA: MR imaging of the normal sella. Am J Neuroradiol 14: 123-127
3. Åkeson P, Vikhoff B, Ståhlberg F, Holtås S (1997) Brain lesion contrast in MR imaging. Dependence on field strength and concentration of gadodiamide injection in patients and phantoms. Acta Radiol 38: 14-18
4. Yuh WTC, Fisher DJ, Runge VM, Atlas SW, Harms SE, Maravilla KR, Mayr NA, Mollman JE, Price AC (1994) Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. Am J Neuroradiol 15: 1037-1051
5. Niendorf HP, Laniado M, Semmler W, Schörner W, Felix R (1987) Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors. Am J Neuroradiol 8: 803-815
6. Maravilla KR (1991) Optimal use of MR contrast agents: How much is enough? Am J Neuroradiol 12: 881-883
7. Haustein J, Laniado M, Niendorf HP, Hilbertz T, Planitzer J, Schörner W, Louton T (1992) Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. Am J Neuroradiol 13: 1199-1206
8. Davis PC, Gokhale KA, Joseph GJ, Peterman SB, Adams DA, Tindall GT, Hudgins PA, Hoffman JC (1991) Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients. Radiology 180: 779-784
9. Chang KH, Ra DG, Han MH, Cha SH, Kim HD, Han MC (1994) Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T. Am J Neuroradiol 15: 1413-1419
10. Åkeson P, Larsson EM, Kristoffersen DT, Jonsson E, Holtås S (1995) Brain metastases: comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging. Acta Radiol 36: 300-306
11. Edal AL, Skjødt K, Nepper-Rasmussen HJ (1997) SIPAP: a new MR classification for pituitary adenomas. Acta Radiol 38: 30-36
12. Agresti A (1990) Categorical data analysis. Wiley, New York
13. Hald JK, Skalpe IO, Bakke SJ, Nakstad PH (1994) MR imaging of pituitary region lesions with gadodiamide injection. Acta Radiol 35: 65-69
14. Lundin P, Bergström K (1992) Gd-DTPA-enhanced MR imaging of pituitary macroadenomas. Acta Radiol 33: 323-332
15. Hald JK, Nakstad PH, Kollevold T, Bakke SJ, Skalpe IO (1992) MR imaging of pituitary macroadenomas before and after transsphenoidal surgery. Acta Radiol 33: 396-399
16. Elster AD (1994) Field strength dependence of gadolinium enhancement. Theory and implications. Am J Neuroradiol 15: 1420-1423
17. Schörner W, Laniado M, Niendorf HP, Schubert C, Felix R (1986) Time-dependent changes in image contrast in brain tumors after gadolinium-DTPA. Am J Neuroradiol 7: 1013-1020
18. Åkeson P, Nordström CH, Holtås S (1997) Time-dependency in brain lesion enhancement with gadodiamide injection. Acta Radiol 38: 19-24